Overexpression of P-glycoprotein in adenomatous hyperplasia of human liver with cirrhosis

Journal of Hepatology

Volumn 22, Issue 2, 1995, Pages 197-201

  Nagasue, Naofumi ^a   Dhar, Dipok Kumar ^a   Makino, Yoshinari ^a   Yoshimura, Hiroshi ^a   Nakamura, Teruhisa ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Adenomatous hyperplasia; Human liver; Multidrug resistance; P glycoprotein.

Indexed keywords

GLYCOPROTEIN P;

ADENOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ADENOMA; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGE; P-GLYCOPROTEIN; STAINING AND LABELING;

EID: 0028947663     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8278(95)80429-3     Document Type: Article

References (29)

1. Expression of a multidrug-resistance gene in human tumors and tissues
2. Expression of a multidrug resistance gene in human cancers
3. Immunohistochemical detection of multidrug resistance associated P-glycoprotien in tumour and stromal cells of human cancers
4. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues
5. 1 gene and P-glycoprotein in human hepatocellular carcinoma
6. Hepatocellular pseudotumor in the cirrhotic liver: report of three cases
7. Emergence of malignang lesions within an adenomatous hyperplastic nodule in a cirrhotic liver: observations in five cases
8. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma
9. Hepatocellular pseudotumour (regenerating nodule) in the cirrhotic liver mimicking hepatocellular carcinoma
10. Cellular biochemistry of the stepwise development of cancer with chemicals: G.H.A.
11. Pleotropic drug resistance in hepatocytes induced by carcinogens administered to rats
12. Conduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics
13. Expression of the multidrug-resistant gen in hepatocarcinogenesis and regenerating rat liver
14. Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in reat preneoplastic liver nodules and hepatocellular carcinoma
15. Cellular pattern of multidrug-resistance gene expression during chemical hepatocarcinogenesis in the rat
16. P-Glycoprotein expression during tumor progression in the rat liver
17. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice
18. The morphology of cirrhosis recommendation on definition nomenclature and classification by a working group sponsored by the World Health Organization
19. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies
20. Use of avidin-biotin-peroxidase technique a comparison between ABC and unlabeled antibody (PAP) procedures
21. Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance
22. Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues
23. Benign epithelial tumors and tumor-like lesions of the liver
24. Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies
25. Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining
26. Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis
27. 1RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants
28. 1 gene in human gastric and colorectal carcinomas
29. Expression of mdr-1/P-glycoprotein in human neuroblastoma